Good Health Can’t Wait.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Good</strong> <strong>Health</strong> <strong>Can’t</strong> <strong>Wait</strong>.<br />
Dr. Reddy’s Laboratories Limited<br />
CONSOLIDATED STATEMENT OF PROFIT AND LOSS<br />
(All amounts in Indian Rupees millions, except share data and where otherwise stated)<br />
PARTICULARS<br />
NOTE<br />
FOR THE YEAR ENDED<br />
31 MARCH 2015<br />
FOR THE YEAR ENDED<br />
31 MARCH 2014<br />
INCOME<br />
Sales, gross 147,855 131,715<br />
Less: Excise duty (829) (820)<br />
Sales, net 147,026 130,895<br />
Service income 1,689 1,632<br />
License fees 369 280<br />
Other operating revenues 2.16 1,149 1,346<br />
Revenue from operations 150,233 134,153<br />
Other income 2.17 2,741 1,697<br />
Total revenue 152,974 135,850<br />
EXPENSES<br />
Cost of material consumed (including packing material consumed) 28,259 28,407<br />
Purchase of stock-in-trade 9,420 7,398<br />
Changes in inventories of finished goods,work-in-progress and stock-intrade<br />
2.18 (558) (3,196)<br />
Conversion charges 1,929 2,207<br />
Employee benefits expense 2.19 29,446 24,754<br />
Finance costs 2.20 1,082 1,267<br />
Depreciation and amortisation expense 2.7 7,599 6,475<br />
Other expenses 2.21 46,801 42,075<br />
Total expenses 123,978 109,387<br />
Profit before exceptional and extraordinary items and tax 28,996 26,463<br />
Exceptional items - -<br />
Profit before extraordinary items and tax 28,996 26,463<br />
Extraordinary items - -<br />
Profit before tax 28,996 26,463<br />
Tax expense 2.22<br />
Current tax expense 6,242 6,568<br />
Deferred tax expense/ (benefit) (610) 263<br />
Profit for the year 23,364 19,632<br />
Earnings per share 2.24<br />
Basic - Par value ` 5/- per share 137.18 115.45<br />
Diluted - Par value ` 5/- per share 136.59 114.90<br />
Number of shares used in computing earnings per share<br />
Basic 170,314,506 170,044,518<br />
Diluted 171,056,969 170,857,689<br />
Significant accounting policies 1<br />
The accompanying notes are an integral part of consolidated financial statements<br />
As per our report of even date attached<br />
for B S R & Co. LLP<br />
Chartered Accountants<br />
for and on behalf of the Board of Directors of Dr. Reddy’s Laboratories Limited<br />
Firm Registration No.: 101248W/W-100022<br />
Supreet Sachdev<br />
Partner K Satish Reddy Chairman<br />
Membership No.: 205385 G V Prasad Co-Chairman & Chief Executive Officer<br />
Place : Hyderabad Saumen Chakraborty President & Chief Financial Officer<br />
Date : 12 May 2015 Sandeep Poddar Company Secretary<br />
170
Change language